CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats
Authors
Keywords
-
Journal
Sleep and Breathing
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-02
DOI
10.1007/s11325-019-02009-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor
- (2018) Saif Deis et al. BONE
- Role of the endogenous cannabinoid receptor 1 in brain injury induced by chronic intermittent hypoxia in rats
- (2018) Xiaoling Gao et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Screening for Obstructive Sleep Apnea in Adults
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
- (2017) Vishesh K. Kapur et al. Journal of Clinical Sleep Medicine
- Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats
- (2017) Michael W Calik et al. SLEEP
- Prevalence of obstructive sleep apnea in the general population: A systematic review
- (2017) Chamara V. Senaratna et al. SLEEP MEDICINE REVIEWS
- Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats
- (2017) Michael W Calik et al. SLEEP
- Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea
- (2016) Xiaoya Wang et al. Biomed Research International
- Role of sleep quality in the metabolic syndrome
- (2016) David Gozal et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
- (2015) Charu Sharma et al. Evidence-based Complementary and Alternative Medicine
- Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome
- (2015) Rabia Terzi et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
- (2015) R Heinzer et al. Lancet Respiratory Medicine
- The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
- (2015) Marie Smith et al. PLoS One
- Association between Sleep Duration, Insomnia Symptoms and Bone Mineral Density in Older Boston Puerto Rican Adults
- (2015) Jinya Niu et al. PLoS One
- Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
- (2014) John M. McPartland et al. PLoS One
- Intermittent Hypoxia Effect on Osteoclastogenesis Stimulated by Neuroblastoma Cells
- (2014) Vasantha Kumar Bhaskara et al. PLoS One
- Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro
- (2011) LS Whyte et al. BRITISH JOURNAL OF PHARMACOLOGY
- Obstructive Sleep Apnea Syndrome in the Sao Paulo Epidemiologic Sleep Study
- (2010) Sergio Tufik et al. SLEEP MEDICINE
- Prevalence and risk factors of obstructive sleep apnea among middle-aged urban Indians: A community-based study
- (2009) Emmadi V. Reddy et al. SLEEP MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started